Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

504.13 (Glytoucan)

Id:3e517e58-9968-563a-ba8d-d46a38cd42a0

Glytoucan:G49589HV

Results found

Linked to

	Label	Description
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G33129LQ-GLYCOSEQ00072455 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G18628GH-GLYCOSEQ00137852 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G69837XX-GLYCOSEQ00159998 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G33129LQ-GLYCOSEQ00072451 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G79764DY-GLYCOSEQ00036709 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G33129LQ-GLYCOSEQ00072454 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has motif 4'-sulfated LDN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G79764DY-GLYCOSEQ00036711 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G18464VS-GLYCOSEQ00093209 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G79764DY-GLYCOSEQ00036710 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G33129LQ-GLYCOSEQ00072455 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G18628GH-GLYCOSEQ00137852 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G69837XX-GLYCOSEQ00159998 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G33129LQ-GLYCOSEQ00072451 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G79764DY-GLYCOSEQ00036709 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G33129LQ-GLYCOSEQ00072454 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has motif 4'-sulfated LDN

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G79764DY-GLYCOSEQ00036711 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G18464VS-GLYCOSEQ00093209 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

504.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G79764DY-GLYCOSEQ00036710 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.